Skip to content
Epomedicine
Epomedicine

Mnemonics, Simplified Concepts & Thoughts

  • Medical Students
  • Bedside Clinics
  • Case Reports
  • Emergency Medicine
  • Blog
  • Surgical Skills
  • Medical Mnemonics
Epomedicine

Mnemonics, Simplified Concepts & Thoughts

heme synthesis pathway

Heme Synthesis and Defects Simplified

Dr. Sulabh Kumar Shrestha, MS Orthopedics, Jul 9, 2016Oct 4, 2016

Last updated on October 4, 2016

Structure of Heme

heme structure

Heme is a ferro-proto-porphyrin.

Heme = Protoporphyrin IX ring + Iron (Fe) in center

Protoporphyrin IX = porphyrin with attachment to 4 Methyl, 2 Propionyl and 2 Vinyl groups.

Porphyrin = Cyclic structure with 4 pyrrole rings

Pyrrole rings are derived from Porphobilinogen (PBG)

Hydroxymethylbilane = Linear structure with 4 pyrrole rings

Uroporphyrobilinogen = Cyclization of hydroxymethylbilane

Steps in Heme Synthesis

Step 1: We need a Pyrrole ring

1. Glycine + Succinyl-CoA = δ-ALA (Amino-Levulinic Acid)

  • Catalyzed by ALA synthase
  • Requires Pyridoxal-phosphate (Vit. B6) for activation of Glycine
  • Rate-limiting enzyme (Repressed by heme)
  • Occurs in mitochondria

2. ALA leaves mitochondria into the cytosol

3. ALA + ALA or 2 X ALA = Porphobilinogen

  • Condensed by ALA dehydratase
  • Inhibited by Lead (Pb)

We now have a pyrrole ring.

Step 2: We need 4 Pyrrole rings

4. 4 X Porphobilinogen = Hydroxymethylbilane or Pre-uroporphyrinogen

  • By Porphobilinogen Deaminase aka Hydroxymethylbilane synthase
  • Hydroxymethylbilane is the 1st porphyrin of the pathway (absorbs light and cause photosensitivity)

Now, we have 4 pyrrole rings arranged linearly.

Step 3: We need a Porphyrin ring

5. Hydroxymethylbilane = Uroporphyrinogen III

  • Cyclization or ring closure by Uroporphyrinogen III synthase

Step 4: We need Proto-porphyrin IX

6. Uroporphyrinogen III = Coproporphyrinogen III

  • Ring modification (removal of 4 CO2) by Uroporphyrinogen Decarboxylase

7. Coproporphyrinogen III leaves cytosol and enters back into mitochondria

8. Coproporphyrinogen III = Proto-porphyrin IX

  • By oxidation reactions

Step 5: We need Heme

Since, heme is a ferro-protoporphyrin – we need to add an iron on the center of the protoporphyrin ring.

9. Proto-porphyrin IX + Fe²+ = Heme

  • By Ferrochelatase
  • Inhibited by lead (Pb)

We have found the Heme !!! Mission accomplished.

heme synthesis pathway

Location of Heme Synthesis

Both the mitochondria and cytosol:

  • ALA leaves mitochondria and Copro-porphyrinogen III enters back into the mitochondria

So, can the RBCs synthesize Heme?

No. RBCs lack mitochondria. So, heme is synthesized in the RBC progenitor cells.

Is Heme synthesized only in RBC precursors?

No. Heme is synthesized in almost every cells because heme is not only the part of hemoglobin but other important molecules as well. These will be discussed below.

Heme as a Component of Important Structures

  1. Hemoglobin
  2. Myoglobin
  3. Cytochromes
  4. Enzymes:
    • Catalase
    • Peroxidase
    • Guanylate cyclase (stimulated by nitric oxide)

Defects in Heme Synthesis

Porphyria in General

As discussed earlier, Hydroxymethylbilane is the 1st porphyrin of the pathway which is able to absorb light and cause photosensitivity. Hence, defects above will have “No Photosensitivity” and defects below will have “Photosensitivity“.

Clinical features depend upon the accumulation of substrates:

Block early in the pathway: Accumulation of ALA

ALA is responsible for neurological symptoms:

  1. Abdominal pain
  2. Neuropsychiatric symptoms
  3. Motor: Muscle weakness
  4. Autonomic: Vomiting, Constipation

Mechanism of ALA toxicity:

  1. Inhibition of ATPase in nervous tissue by ALA
  2. ALA may be taken up by brain which causes conduction paralysis

Block later in the pathway: Accumulation of porphyrinogens

Porphyrinogen accumulation is responsible for photosensitivity.

Mechanism of photosensitivity:

  1. Porphyrinogens absorbs light and auto-oxidizes to corresponding Porphyrin derivatives.
  2. These porphyrins react with molecular oxygen to form oxygen radicals in the skin.
  3. Oxygen radicals damage lysososmes which further releases degradative enzymes.
  4. This leads to skin damage.

Exacerbated by P450 inducing drugs:

  • Cytochrome P450 induction = Increased synthesis of Cytochrome P450 (has heme as a component) = Decreased heme levels = Decreased repression of ALA synthase = Increased porphyrin precursor synthesis
  • Examples:
    1. Barbiturates
    2. Alcohol
    3. Cigarette smoking
    4. Anticonvulsants
    5. Horomones

Fasting-induced porphyria and Role of glucose infusion:

Fasting increases the level of a protein, proliferator-activated receptor γ coactivator 1α (PGC-1α), which is involved in creating glucose in the liver. They also found that this protein regulates a key enzyme in the heme biosynthesis pathway, 5-aminolevulinate synthase (ALAS-1). Increased levels of PGC-1α resulted in increased production of ALAS-1. This in turn led to a build-up of precursor heme molecules, which, caused acute attacks of porphyria. 1Secko D. Link between porphyria and fasting uncovered. CMAJ. 2005 Oct 11;173(8):864. PubMed PMID: 16217104; PubMed Central PMCID: PMC1247695

Photo-sensitivity may be benefited by beta-carotene: Anti-oxidant

Inheritance Pattern of porphyria:

Porphyria is caused as a result of diminished feedback inhibition by end-product due to enzyme deficiencies. Hence, these are autosomal dominant disorders with exception to Congenital Erythropoietic Porphyria which is autosomal recessive.

Lead toxicity can causes Acquired form of Porphyria by inhibiting 2 enzymes:

  1. ALA dehydratase
  2. Ferrochelatase

Types of Porphyria according to Enzyme Defects:

  1. ALA synthase: X-linked Porphyria
  2. ALA dehydratase: Inhibited in Lead poisoning
  3. Porphobilinogen deaminase or Hydroxymethylbilane synthase: Acute Intermittent Porphyria
  4. Uroporphyrinogen III synthase: Congenital erythropoietic porphyria
  5. Uroporphyrinogen decarboxylase: Porphyria cutanea tarda; Also inhibited by hexachlorobenzene (BHC)
  6. Coproporphyrinogen oxidase: Coproporphyria
  7. Protoporphyrinogen oxidase: Variegate porphyria
  8. Ferrochelatase: Protoporphyria; Also inhibited in lead poisoning

Hepatic Vs Erythropoietic porphyria: Based on the site where heme synthesis is active –

Erythropoietic porphyrias (Bone marrow):

  1. Congenital erythropoietic porphyria
  2. Protoporphyria

Hepatic porphyrias (Liver): Others

Porphyria Cutanea Tarda:

  • Defect in uroporphyrinogen decarboxylase
  • Autosomal dominant
  • Most common porphyria
  • Late onset (4th or 5th decade)
  • Exacerbated by hepatotoxic susbstances as it is a heaptic form of porphyria:
    • Alcohol
    • Iron
  • Accumulation of uroporphyrin:
    • Photosensitivity
    • Hyperpigementation (Body’s attempt to protect the skin)
    • Characteristic red-wine urine

Acute Intermittent Porphyria:

  • Defect in Porphobilinogen Deaminase
  • Autosomal dominant
  • Late onset
  • No porphyrin – No photosensitivity
  • Accumulation of ALA:
    • Abdominal pain
    • Episodic psychological symptoms – anxiety, confusion, paranoia, depression
    • Exacerbated by barbiturates
  • Dark red/brown colored urine: ALA and PBG in urine

heme-synthesis-porphyria

Mnemonic

All Congenital Porphyria Comprise Variable Presentation

Remember the pathway and correlate with the mnemonic sequentially.

  1. All = Acute Intermittent Porphyria (PB deaminase)
  2. Congenital = Congenital Erythropoietic Porphyria (Uroporphyrinogen III synthase)
  3. Porphyria = Porphyria Cutanea Tarda (Uroporphyrinogen decarboxylase)
  4. Comprise = Coproporphyria (Coproporphyrinogen oxidase)
  5. Variable = Variegate Porphyria (Protoporphyrinogen oxidase)
  6. Presentation = Protoporphyria (Ferrochelatase)

Hemin

Occurs when Fe³+ is incorporated in proto-porphyrin instead of Fe²+

Used in treatment of acute attacks of porphyria particularly Acute Intermittent Porphyria

Mechanism of Action:

Reduce incorporation of glycine into cellular heme, significantly inhibited formation of protoporphyrin IX and total delta-aminolevulinate. 2Gardner LC, Smith SJ, Cox TM. Biosynthesis of delta-aminolevulinic acid and the regulation of heme formation by immature erythroid cells in man. J Biol Chem. 1991 Nov 15;266(32):22010-8. PubMed PMID: 1939222

Antimalarial action:

  1. Malarial parasites are rich in hemin; artemisinin’s reactivity toward hemin may explain its selective toxicity to malarial parasites. 3Meshnick SR, Thomas A, Ranz A, Xu CM, Pan HZ. Artemisinin (qinghaosu): the role of intracellular hemin in its mechanism of antimalarial action. Mol Biochem Parasitol. 1991 Dec;49(2):181-9. PubMed PMID: 1775162.
  2. Hemin-chloroquine complex is toxic to parasites. 4Encyclopedia of Parasitology By Heinz Mehlhorn

Lead Poisoning

ALA dehydratase and Ferrochelatase are Zn²+ dependent metallo-enzymes. Pb2+ replaces the Zn2+ at the active site and inhibits them.

Features:

  1. Microcytic sideroblastic anemia
  2. Coarse basophilic stippling of RBCs
  3. Increase in ALA without increase in PBG (differentiate from other porphyrias)
  4. Increased free erythrocyte protoporphyrin
  5. Lead lines in gum, Neuropathy, Abdominal pain, Nephrotoxicity (deposition in PCT)
  6. Headache, nausea, memory loss

Vitamin B6 deficiency

ALA synthase requires Vit. B6 (pyridoxine)

Explains sideroblastic anemia with Isoniazid therapy

Iron deficiency

Iron is incorporated into protoporphyrin in the last step to form heme.

Deficiency results in microcytic hypochromic anemia

  • Cytoplasmic maturation defect while the nuclear maturation is intact
dr. sulabh kumar shrestha
Dr. Sulabh Kumar Shrestha, MS Orthopedics

He is the section editor of Orthopedics in Epomedicine. He searches for and share simpler ways to make complicated medical topics simple. He also loves writing poetry, listening and playing music.

1 shares
  • Facebook1
  • Twitter
PGMEE, MRCS, USMLE, MBBS, MD/MS BiochemistryHematology

Post navigation

Previous post
Next post

Comments (9)

  1. Douglas k says:
    Oct 4, 2016 at 11:08 am

    Just what i needed. Thank you

    Reply
    1. Dr kheni says:
      Feb 10, 2023 at 5:44 pm

      Best way explained…easy to understand basic…thank you.

      Reply
  2. Clinton A. says:
    May 3, 2017 at 7:49 pm

    marvellous…!!! easily understandable presentation of mechanisms of action….really helpful!

    Reply
  3. HARINI MOHAN says:
    Oct 13, 2017 at 12:05 pm

    Really helpful article.. gained a lot of important points.. thanks a lot 😊

    Reply
  4. Dr. Raj says:
    May 22, 2018 at 8:40 am

    very useful and within in a limited content

    Reply
  5. maneesha says:
    Jun 11, 2018 at 10:46 am

    extremely good

    Reply
  6. S says:
    Feb 16, 2022 at 7:53 am

    you didn’t leave anything out!
    Excellent contents

    Reply
  7. sam says:
    Feb 17, 2024 at 1:23 am

    Excellent presentation of relevant facts! Just what i needed.

    Reply
  8. Pooja shrestha says:
    Jul 4, 2024 at 6:59 am

    very helpful.

    Reply

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Shrestha SK. Heme Synthesis and Defects Simplified [Internet]. Epomedicine; 2016 Jul 9 [cited 2025 May 16]. Available from: https://epomedicine.com/medical-students/heme-synthesis/.

Pre-clinical (Basic Sciences)

Anatomy

Biochemistry

Community medicine (PSM)

Embryology

Microbiology

Pathology

Pharmacology

Physiology

Clinical Sciences

Anesthesia

Dermatology

Emergency medicine

Forensic

Internal medicine

Gynecology & Obstetrics

Oncology

Ophthalmology

Orthopedics

Otorhinolaryngology (ENT)

Pediatrics

Psychiatry

Radiology

Surgery

RSS Ask Epomedicine

  • What to study for Clinical examination in Orthopedics?
  • What is the mechanism of AVNRT?

Epomedicine weekly

  • About Epomedicine
  • Contact Us
  • Author Guidelines
  • Submit Article
  • Editorial Board
  • USMLE
  • MRCS
  • Thesis
©2025 Epomedicine . All rights reserved.